Opus Genetics, Inc. (IRD)
5.35
+0.09
(+1.71%)
USD |
NASDAQ |
May 07, 16:00
5.26
-0.09
(-1.68%)
After-Hours: 20:00
Opus Genetics Research and Development Expense (Annual) : 30.81M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Keros Therapeutics, Inc. | 127.09M |
| Moderna, Inc. | 2.917B |
| ACADIA Pharmaceuticals, Inc. | 328.80M |
| Alnylam Pharmaceuticals, Inc. | 1.320B |
| Savara, Inc. | 81.40M |